Aventis Pasteur S.A.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 9246
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
  
 
C07K PEPTIDES 1135
 
  
 
C08B POLYSACCHARIDES; DERIVATIVES THEREOF 130
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
7812006 Conjugates obtained by reductive amination of the pneumococcus serotype 5 capsular polysaccharideJan 15, 04Oct 12, 10[A61K, C07H, C12P, C08B]
7767658 Vaccine compositionJan 09, 08Aug 03, 10[A61K]
7404960 Multivalent vaccine composition having increased stability of capsular polysaccharideJul 31, 02Jul 29, 08[A61K]
7344720 Vaccine compositionNov 15, 04Mar 18, 08[A61K]
6472159 Use of an amphipathic compound for providing an adjuvant to a subunit vaccineApr 16, 01Oct 29, 02[A61K, C12Q, G01N]
6028049 Compositions comprising the Tbp2 subunit of the transferrin receptor of Neisseria meningitidisMay 23, 95Feb 22, 00[A61K, C07K]
5928650 Subunit vaccine against Neisseria meningitidis infections and corresponding subunits in the purified stateMay 25, 95Jul 27, 99[A61K]
5618540 Subunit vaccine against Neisseria meningitidis infections and corresponding subunits in the purified stateMay 25, 93Apr 08, 97[A61K]
5618541 Vaccine against Neisseria meningitidis infectionsJun 02, 93Apr 08, 97[A61K]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
7320874 Assaying the teichoic acids of gram.sup.+ bacteriaExpiredJul 06, 04Jan 22, 08[G01N]
7122094 Method and apparatus for sterile connection between two flexible tubesExpiredDec 22, 00Oct 17, 06[B29C]
2006/0140,981 Intranasal delivery of pneumococcal polysaccharide vaccinesAbandonedFeb 21, 06Jun 29, 06[A61K]
7056519 Methods for inducing HIV-neutralizing antibodiesExpiredMay 15, 03Jun 06, 06[A61K]
6982088 Vaccine composition and stabilization method using high molecular weight PVPExpiredOct 08, 01Jan 03, 06[A61K]
6927235 Vaccine composition comprising iron phosphate as vaccine adjuvantExpiredMay 14, 04Aug 09, 05[A01N]
2005/0118,188 Pharmaceutical composition for immunization against AIDSAbandonedOct 01, 04Jun 02, 05[A61K]
6861253 Polypeptide inducing antibodies neutralizing HIVExpiredJan 07, 02Mar 01, 05[C12N]
2005/0002,952 Adjuvant for vaccine compositionAbandonedApr 29, 04Jan 06, 05[A61K]
6821723 GP41 antigenExpiredOct 02, 02Nov 23, 04[A61K, C12Q, C12N]
6780421 Adjuvant for a vaccine compositionExpiredSep 09, 97Aug 24, 04[A61K]
6737067 Trimer of HIV env gene expression productExpiredApr 18, 01May 18, 04[A61K]
2004/0058,861 Use of lipopeptides in immunotherapy of HIV+ individualsAbandonedSep 07, 01Mar 25, 04[A61K]
2004/0005,330 Mutated HIV TatAbandonedDec 05, 02Jan 08, 04[A61K, C07H, C12P, C12N, C07K]
6664049 Method and device for cell lysisExpiredMar 21, 01Dec 16, 03[C07H, C12Q, C12M]
6641816 Use of poxviruses as enhancer of specific immunityExpiredMar 09, 01Nov 04, 03[A61K, C12N]
2003/0190,326 Pharmaceutical composition for immunisation against aidsAbandonedMar 31, 03Oct 09, 03[A61K, C07H, C07K]
6610308 Immunostimulant emulsionExpiredJun 27, 01Aug 26, 03[A61K, C07H]
6596861 Method for the reductive amination of polysaccharidesExpiredJan 18, 02Jul 22, 03[C07H]
2003/0104,613 Method for producing adherent animal cellsAbandonedOct 09, 02Jun 05, 03[C12N]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.